Immobilized PAD4 enzyme on magnetic nanoparticles for screening natural inhibitors from traditional Chinese medicines
Author:
Zhao Zeyuan,
Wang Chenyang,
Zhao Juanjuan,
Li Yanfeng,
Zhang Shengxiang,
Dong Jianhui,
Zuo Haiyue,
Ou Junjie,
Deng Nan,
Bian YangyangORCID
Reference45 articles.
1. Interrogation of the active sites of protein arginine deiminases (PAD1, -2, and -4) using designer probes;Bello;ACS Med. Chem. Lett.,2013
2. Novel peptidylarginine deiminase type 4 (PAD4) inhibitors;Sabnis;ACS Med. Chem. Lett.,2022
3. Substrate specificity and kinetic studies of PADs 1, 3, and 4 identify potent and selective inhibitors of protein arginine deiminase 3;Knuckley;Biochem,2010
4. PAD4 and its inhibitors in cancer progression and prognosis;Zhu;Pharmaceutics,2022
5. Peptidylarginine deiminase isozyme specific PAD2, PAD3 and PAD4 inhibitors differentially modulate extracellular vesicle signatures and cell invasion in two glioblastoma multiforme cell lines;Uysal Onganer;Int. J. Mol. Sci.,2020